Increased DNA vaccine delivery and immunogenicity by electroporation in vivo
- PMID: 10779767
- DOI: 10.4049/jimmunol.164.9.4635
Increased DNA vaccine delivery and immunogenicity by electroporation in vivo
Abstract
DNA vaccines have been demonstrated to be potent in small animals but are less effective in primates. One limiting factor may be inefficient uptake of DNA by cells in situ. In this study, we evaluated whether cellular uptake of DNA was a significant barrier to efficient transfection in vivo and subsequent induction of immune responses. For this purpose, we used the technique of electroporation to facilitate DNA delivery in vivo. This technology was shown to substantially increase delivery of DNA to cells, resulting in increased expression and elevated immune responses. The potency of a weakly immunogenic hepatitis B surface Ag DNA vaccine was increased in mice, as seen by a more rapid onset and higher magnitude of anti-hepatitis B Abs. In addition, the immunogenicity of a potent HIV gag DNA vaccine was increased in mice, as seen by higher Ab titers, a substantial reduction in the dose of DNA required to induce an Ab response, and an increase in CD8+ T cell responses. Finally, Ab responses were enhanced by electroporation against both components of a combination HIV gag and env DNA vaccine in guinea pigs and rabbits. Therefore, cellular uptake of DNA is a significant barrier to transfection in vivo, and electroporation appears able to overcome this barrier.
Similar articles
-
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.J Immunol. 2000 Sep 1;165(5):2850-8. doi: 10.4049/jimmunol.165.5.2850. J Immunol. 2000. PMID: 10946318
-
Accelerated immune response to DNA vaccines.DNA Cell Biol. 2003 Dec;22(12):815-22. doi: 10.1089/104454903322625028. DNA Cell Biol. 2003. PMID: 14683592
-
Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.Vaccine. 2006 Apr 5;24(15):2755-63. doi: 10.1016/j.vaccine.2006.01.013. Epub 2006 Jan 19. Vaccine. 2006. PMID: 16460840
-
Helper independent recombinant adenovirus vectors: expression of HIV env or HBV surface antigen.Int Rev Immunol. 1990;7(1):67-77. doi: 10.3109/08830189009061765. Int Rev Immunol. 1990. PMID: 2132880 Review. No abstract available.
-
Induction of immune responses by DNA vaccines in large animals.Vaccine. 2003 Jan 30;21(7-8):649-58. doi: 10.1016/s0264-410x(02)00574-1. Vaccine. 2003. PMID: 12531334 Review.
Cited by
-
Daedalic DNA vaccination against self antigens as a treatment for chronic kidney disease.Int J Clin Exp Pathol. 2013;6(3):326-33. Epub 2013 Feb 15. Int J Clin Exp Pathol. 2013. PMID: 23412421 Free PMC article. Review.
-
A mouse model for studying the clearance of hepatitis B virus in vivo using a luciferase reporter.PLoS One. 2013;8(4):e60005. doi: 10.1371/journal.pone.0060005. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577080 Free PMC article.
-
DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?Genet Vaccines Ther. 2012 Oct 9;10(1):9. doi: 10.1186/1479-0556-10-9. Genet Vaccines Ther. 2012. PMID: 23046944 Free PMC article.
-
[Trends in vaccine development].Pharm Unserer Zeit. 2008;37(1):86-92. doi: 10.1002/pauz.200700246. Pharm Unserer Zeit. 2008. PMID: 18081053 Free PMC article. Review.
-
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment.PLoS One. 2009 Sep 30;4(9):e7226. doi: 10.1371/journal.pone.0007226. PLoS One. 2009. PMID: 19789652 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials